WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹4.95 Cr | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr | ₹3.59 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹4.95 Cr |
Mar2024 | ₹3.95 Cr |
Mar2023 | ₹3.44 Cr |
Mar2022 | ₹0.21 Cr |
Mar2021 | ₹3.59 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹4.95 Cr | 25.46 | |
Mar2024 | ₹3.95 Cr | 14.84 | |
Mar2023 | ₹3.44 Cr | 1,513.62 | |
Mar2022 | ₹0.21 Cr | -94.06 | |
Mar2021 | ₹3.59 Cr | - |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,219.3 Cr | 14.5% | 14.5% | 8.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 2.6% | -5.1% | -6.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -0.5% | -10.1% | 21.8% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 4.7% | 4.8% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 0.6% | 5.2% | 8.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 4.3% | -0.7% | -11.4% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | 14.5% |
14.5% |
8.3% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses